Doctor of Surgery, Associate Professor, Associate Chief Physician, and Master's Supervisor. He received advanced surgical training at the Royal College of Surgeons of Edinburgh and the College of Surgeons of Hong Kong, and is a Fellow of the Fudan-Harvard Global Clinical Scholars Program.He has long been engaged in surgical treatment of hepatobiliary tumors, liver transplantation and clinical translational research. He specializes in minimally invasive (robotic and laparoscopic) resection of hepatobiliary tumors and liver transplantation, and has completed and participated in numerous innovative high-complexity surgical procedures.His research focuses on immunotherapy and clinical translational research for liver cancer. As the first or corresponding author, he has published more than 30 SCI papers in journals including Hepatology, Cancer Res, Oncogene, Cell Discov, JITC and BMC Med. He has presided over 3 projects supported by the National Natural Science Foundation of China, and participated as a principal investigator in multiple clinical research projects of the institution such as the 863 Program and major special projects of Shanghai Municipality. He is the recipient of awards including the Academic Newcomer Award from the Ministry of Education, the Rising Star in Science and Technology of Zhongshan Hospital, and the Good Doctor of the People - Jinshan Camellia Award (2023, 2024). He has been selected into multiple talent programs sponsored by the Ministry of Education and Shanghai Municipality.